Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,200,337
-$242,819 QoQ
Shares Held
17,416
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#803
of 2,266 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. GILD ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,200,337 | 17,416 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,443,156 | 17,530 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,135,147 | 25,543 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,351,201 | 30,191 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,019,844 | 126,453 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,739,821 | 149,396 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,005,193 | 324,837 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,421,173 | 338,993 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,584,961 | 343,754 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,030,028 | 328,055 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,281,426 | 324,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,972,479 | 373,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,525,071 | 370,119 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,462,459 | 294,835 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,881,332 | 324,768 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,340,606 | 345,933 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,598,862 | 333,261 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||